Concept paper on the need for revision of the guideline on clinical investigation of medicinal products in the treatment of depression
|
|
- Derick Lucas
- 5 years ago
- Views:
Transcription
1 Nvember 2016 EMA/CHMP/183826/2016 Cmmittee fr Medicinal Prducts fr Human Use (CHMP) Cncept paper n the need fr revisin f the guideline n clinical investigatin f medicinal prducts in the treatment f depressin 8 Agreed by Central Nervus System Wrking Party Octber 2016 Adpted by CHMP fr release fr cnsultatin 10 Nvember 2016 Start f public cnsultatin 18 Nvember 2016 End f cnsultatin (deadline fr cmments) 28 February The prpsed guideline will replace 'Guideline n clinical investigatin f medicinal prducts in the treatment f depressin' (CPMP/EWP/518/97, Rev. 2) Cmments shuld be prvided using this template. The cmpleted cmments frm shuld be sent t CNSWPsecretariat@ema.eurpa.eu Keywrds Majr Depressin, Treatment Resistant Depressin, Partial Respnse, Antidepressants, Augmentatin Strategies, Cgnitive Dysfunctin Churchill Place Canary Wharf Lndn E14 5EU United Kingdm Telephne +44 (0) Facsimile +44 (0) Send a questin via ur website An agency f the Eurpean Unin Eurpean Medicines Agency, Reprductin is authrised prvided the surce is acknwledged.
2 Intrductin Majr Depressive Disrder (MDD) is ne f the mst cmmn psychiatric disrders, which is the furth leading cause f glbal disease burden and affects abut 15 % f the general ppulatin. As utlined in the guidance dcument MDD is nt a benign disrder and risk f suicide is cnsiderable. Althugh a brad therapeutic armamentarium fr treatment f majr depressive episdes (MDE) is available, still abut ne-third f patients treated fr the cnditin d nt respnd satisfactrily t the first antidepressant prescribed 1-4. Incmplete treatment respnse r treatment resistance have been described cmmnly in up t 50 % f the treated patient ppulatin 3,5,6. The current guideline distinguishes between requirements fr trials t study mntherapy in treatment resistant depressin (TRD) and trials t study augmentatin/add-n treatment in case f insufficient respnse t mntherapy. Hwever, in light f the mst up t date evidence generated, the definitin and identificatin f partial respnders needs t be revisited. In clinical practice, mrever, augmentatin and cmbinatin strategies in TRD appear valid appraches 7. Several aspects fr different trial designs in these difficult patients (TRD and partial respnders) therefre require recnsideratin 8. A paradigm shift is taking place in psychiatry where increasingly separate dmains in the brader cntext f a categrical disrder are studied separately 9 and may becme the target f drug develpment if sufficient ratinale exists in supprt. The treatment f specific symptms within the disrder is als reflected in the Diagnstic and Statistical Manual f Mental Disrders, Fifth Editin (DSM 5). As e.g. cgnitive disturbances are paramunt acrss CNS disrders and may warrant a distinct apprach, this will challenge new drug develpment in the cming years T supprt a separate claim fr efficacy n cgnitive aspects in patients with MDD, specific studies shuld be perfrmed 13. It depends n the rbustness f the results whether a separate indicatin can be pursued r whether the data shuld rather be mentined in sectin 5.1. Fr applicatin f an indicatin n cgnitive aspects in patients with MDD a specific effect n cgnitive functin needs t be shwn that culd clearly be disentangled frm the verall depressive symptms. The current guidance lacks recmmendatins with respect t cgnitive functin in MDD. In additin, a number f methdlgical issues in the way clinical trials in depressin are cnducted are nw being discussed in the scientific cmmunity including the reasns fr increasing placeb respnse and the adequateness f the measures f utcme These issues, tgether with the need t accunt fr ppulatin differences in terms f gender and drug metablism might need regulatry guidance. Altgether, the apparent changes in the cnceptual framewrk f psychiatric diseases expressed in the DSM 5, the unmet medical need in TRD and insufficient treatment respnders, and the recgnitin f specific treatment targets acrss disrders, warrant recnsideratin f strategies in clinical trial design, recruitment f patient ppulatins and definitins f endpints. Hence, several amendments f the depressin guideline as well a recnsideratin/recnfirmatin f existing principles need discussin. 2. Prblem statement The current guideline needs revisin cvering the latest develpments with regard t requirements fr clinical trials in partial and nn-respnders with MDD and ptins f targeting new functinal dmains. In additin, it may include requirements t increase depressin clinical trials efficiency. Cncept paper n the need fr revisin f the guideline n clinical investigatin f medicinal prducts in the treatment f depressin EMA/CHMP/183826/2016 Page 2/5
3 Discussin (n the prblem statement) In the prpsed update f the guidance dcument, the fllwing issues will be discussed: Definitin f target ppulatin: general MDD ppulatin, treatment resistant depressin and partial respnders: Diagnstic criteria Age and gender sensitivity Presence f c-mrbidities Crss cultural differences, e.g. nn-eu (e.g. US) data t EU ppulatins 65 Design strategies: Chice f cmparatr Apprpriate endpints Usefulness f cmbinatin therapies and crrespnding study designs, e.g. add-n and augmentatin Placeb effect 71 Cgnitive deficit as a separate dmain in depressin: Definitin f cgnitive disturbances in depressin Trial design strategies Recmmendatin In cnclusin, it is recmmended t update the current Guideline n clinical investigatin f medicinal prducts in the treatment f depressin. Althugh sme f the key issues f guidance have nt changed, mre elabrate recmmendatins culd be given t increase clinical trial efficiency maintaining the validity f the cnclusins. Updated recmmendatins are especially needed n the cnduct f trials in TRD and partial respnders. New guidance n the requirements t supprt specific separate claims, e.g. n cgnitin, shuld als be included. The anticipated changes are cnsidered substantial enugh t recmmend a public cnsultatin. T ensure unifrmity f clinical studies and t set standards, the CNS Wrking Party (CNSWP) recmmends revising the guideline. 5. Prpsed timetable It is planned t release fr cnsultatin a draft CHMP guidance dcument nt later than Sep Resurce requirements fr preparatin The preparatin f this guideline will invlve the CNSWP. Drafts f the dcument will be discussed with Bistatistics Wrking Party (BSWP), Scientific Advice Wrking Party (SAWP) and ther relevant WPs and cmmittees. 90 Cncept paper n the need fr revisin f the guideline n clinical investigatin f medicinal prducts in the treatment f depressin EMA/CHMP/183826/2016 Page 3/5
4 Impact assessment (anticipated) It is expected that the update f the Guideline will be helpful t achieve cnsensus in the evaluatin f medicinal prducts fr the treatment f MDD by regulatry authrities in the Eurpean Cmmunity. Furthermre, it is expected, that such guideline will prvide guidance with respect t methdlgy, assessment tls and clinically relevant utcmes in a) Majr Depressive Disrder (MDD) b) Partial respnders with MDD c) Treatment Resistant Depressin (TRD) d) Cgnitive disturbances in depressin and thus wuld imprve quality and cmparability f develpment prgrams fr these specific indicatins by pharmaceutical cmpanies. 8. Interested parties The interested parties in the guidance dcument include learned scieties and academia (e.g. Eurpean Cllege f Neurpsychpharmaclgy (ECNP) and thers), pharmaceutical industry (e.g. EFPIA and thers) and ther regulatry agencies. 9. References t literature, guidelines, etc. 1 Brent, D.A. & Birmaher, B. Treatment-resistant depressin in adlescents: recgnitin and management. Child Adlesc Psychiatr Clin N Am 15, , x (2006). 2 Keller, M.B. Issues in treatment-resistant depressin. J Clin Psychiatry 66 Suppl 8, 5-12 (2005). 3 Thase, M.E. & Rush, A.J. When at first yu dn't succeed: sequential strategies fr antidepressant nnrespnders. J Clin Psychiatry 58 Suppl 13, 23-9 (1997) 4Rush AJ, et al. Sequenced treatment alternatives t relieve depressin (STAR*D): ratinale and design. Cntrl Clin Trials 2004;25: Suery, D., Papakstas, G.I. & Trivedi, M.H. Treatment-resistant depressin. J ClinPsychiatry 67 Suppl 6, (2006). 6 Fava, M. Diagnsis and definitin f treatment-resistant depressin. Bil Psychiatry 53, (2003). 7 McIntyre RS et al. Treatment resistant depressin: definitins, review f the evidence, and algrithmic apprach. J Affect Disrd 2014; 156:1-7 8Iven N et al. Des the presence f an pen-label antidepressant treatment perid influence study utcme in clinical trial examining augmetnatin/cmbiantin strategies in treatment partial respnders/nnrespnders with majr depressive disrder? J Clin Psychiatry 2012; 73 (5): Williams LM et al. Develping a clinical translatinal neurscience taxnmy fr anxiety and md disrder: prtcl fr the baseline-fllw up Research dmain criteria Anxiety and Depressin ( RAD ) prject. BMC Psychiatry Mar 15;16(1):68 10 Papakstas GI Antidepressants and their effect n cgnitin in majr depressive disrder. J Clin Psychiatry Aug; 76(8) Cncept paper n the need fr revisin f the guideline n clinical investigatin f medicinal prducts in the treatment f depressin EMA/CHMP/183826/2016 Page 4/5
5 McIntyre RS et al. The Prevalence, Measurement, and Treatment f the Cgnitive Dimensin/Dmain in Majr Depressive Disrder. CNS Drugs : Malhi GS et al. Md disrders: neurcgnitive mdels. Biplar Disrd Dec;17 Suppl 2: Trivedi MH et Greer TL Cgnitive dysfunctin in uniplar depressin: implicatins fr treatment. J Affect Disrd Jan; : Ivien N et Papakstas GI Crrelatin between different levels f placeb respnse rate and clinical trial utcme in majr depressive disrder: a meta-analysis. J Clin Psychiatry 2012 Oct;73(10) 15 Leuchter AF et al. Rle f pill-taking, expecatin and therapeutic alliance in the placeb respnse in clinical trials fr majr depressin. Br J Psychiatry 2014;205: Pecina M et al. Placeb-activated neural systems are linked t antidepressant respnses: Neurchemistry f placeb effects in majr depressin. JAMA Psychiatry 2015 Nv;72(11): Rse SP et al. Practising evidence-based medicine in an era f high placeb respnse: number needed t treat recnsidered. Br J Psychiatry 2016 May;208(5): Cncept paper n the need fr revisin f the guideline n clinical investigatin f medicinal prducts in the treatment f depressin EMA/CHMP/183826/2016 Page 5/5
Structured Assessment using Multiple Patient. Scenarios (StAMPS) Exam Information
Structured Assessment using Multiple Patient Scenaris (StAMPS) Exam Infrmatin 1. Preparing fr the StAMPS assessment prcess StAMPS is an assessment mdality that is designed t test higher rder functins in
More informationCorporate Governance Code for Funds: What Will it Mean?
Crprate Gvernance Cde fr Funds: What Will it Mean? The Irish Funds Industry Assciatin has circulated a draft Vluntary Crprate Gvernance Cde fr the Funds Industry in Ireland. 1. Backgrund On 13 June 2011,
More informationACSQHC National Consensus Statement: Essential Elements for High Quality End-oflife Care in Acute Hospitals.
27 March 2014 Prfessr Debra Picne Chief Executive Officer Australian Cmmissin n Safety and Quality in Health Care c/ Ms Jennifer Hill, Senir Prject Officer Level 5, 255 Elizabeth Street SYDNEY NSW 2000
More informationRelated Policies None
Medical Plicy MP 3.01.501 Guidelines fr Cverage f Mental and Behaviral Health Services Last Review: 8/30/2017 Effective Date: 8/30/2017 Sectin: Mental Health End Date: 08/19/2018 Related Plicies Nne DISCLAIMER
More informationTraining module 1: Summary
Draft (Step 2) guideline ICH E9(R1) Estimands and Sensitivity Analysis in Clinical Trials Training mdule 1: Summary Addendum t ICH E9 Statistical Principles fr Clinical Trials ICH E9(R1) Expert Wrking
More informationAssessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams
Assessment Field Activity Cllabrative Assessment, Planning, and Supprt: Safety and Risk in Teams OBSERVATION Identify a case fr which a team meeting t discuss safety and/r safety planning is needed r scheduled.
More informationEUROPEAN MEDICINES AGENCY DECISION. of 14 October 2008
Eurpean Medicines Agency Dc. Ref. EMEA/522876/2008 P/84/2008 EUROPEAN MEDICINES AGENCY DECISION f 14 Octber 2008 n the applicatin fr agreement f a Paediatric Investigatin Plan fr valsartan (Divan) (EMEA-000005-PIP01-07)
More informationQ 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?
updated 2012 Relaxatin training Q 5: Is relaxatin training better (mre effective than/as safe as) than treatment as usual in adults with depressive episde/disrder? Backgrund The number f general health
More informationPart 1 describes the reasoning and recommendations up to node 2 of the algorithm.
Presented by: David Osser, MD Assciate Prfessr f Psychiatry Harvard Medical Schl Dr. Osser has n cnflicts f interest t disclse. This dcument is a summary f selected clinical pearls frm Dr. Osser s presentatin:
More informationPET FORM Planning and Evaluation Tracking ( Assessment Period)
Divisin f: Behaviral Studies PET FORM Planning and Evaluatin Tracking (2010 2011 Assessment Perid) Persn Respnsible fr this Divisin: Jerry Mller Department f: Behaviral Sciences Persn Respnsible fr this
More informationClinical Orthopaedic Rehabilitation Spinal Disorders
COURSE DESCRIPTION Clinical Orthpaedic Rehabilitatin Spinal Disrders This prgram is a practical, clinical guide that prvides guidance n the evaluatin, differential diagnsis, treatment and rehabilitatin
More informationSeeking and Appraising Evidence
EWMA Educatinal Develpment Prgramme Curriculum Develpment Prject Educatin Mdule: Seeking and Appraising Evidence Latest review: August 2012 Educatin Mdule: Seeking and Appraising Evidence ABOUT THE EWMA
More informationCLINICAL MEDICAL POLICY
Plicy Name: Plicy Number: Respnsible Department(s): CLINICAL MEDICAL POLICY Supervised Exercise Therapy fr Peripheral Artery Disease (PAD) MP-077-MD-DE Medical Management Prvider Ntice Date: 01/15/2019
More informationUS Public Health Service Clinical Practice Guidelines for PrEP
Webcast 1.3 US Public Health Service Clinical Practice Guidelines fr PrEP P R E S ENTED BY: M A R K T H R U N, M D A S S O C I AT E P R O F E S S O R, U N I V E R S I T Y O F C O L O R A D O, D I V I S
More information2018 CMS Web Interface
CMS Web Interface MH-1 (NQF 0710): Depressin Remissin at Twelve Mnths Measure Steward: MNCM CMS Web Interface V2.1 Page 1 f 27 06/25/ Cntents INTRODUCTION... 4 CMS WEB INTERFACE SAMPLING INFORMATION...
More informationIll Health. Unit reference number: L/616/7295 Level: 3. Credit value: 3 Guided learning hours: 16. Unit summary
Unit 11: Understand Mental Ill Health Unit reference number: L/616/7295 Level: 3 Unit type: Optinal Credit value: 3 Guided learning hurs: 16 Unit summary Mental ill health culd be ne f the mst serius health
More informationThe principles of evidence-based medicine
The principles f evidence-based medicine By the end f this mdule yu shuld be able t: Describe what evidence based medicine is Knw where t find quality evidenced based medicine n the internet Be able t
More informationModule 6: Goal Setting
Mdule 6: Gal Setting Objectives T understand the cncept f gal setting in Brief CBT T acquire skills t set feasible and apprpriate gals in Brief CBT What is gal setting, and why is it imprtant t set gals
More informationOTHER AND UNSPECIFIED DISORDERS
OPTUM COVERAGE DETERMINATION GUIDELINE OTHER AND UNSPECIFIED DISORDERS Guideline Number: BH727OUD_102017 Effective Date: Octber, 2017 Table f Cntents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS...
More informationPolicy. Medical Policy Manual Approved: Do Not Implement Until 1/1/18. Applied Behavioral Analysis (ABA)
Plicy Medical Plicy Manual Apprved: D Nt Implement Until 1/1/18 Applied Behaviral Analysis (ABA) This medical plicy will apply t self-funded grups upn their renewal, beginning 1/1/18. Des nt apply t BlueCare.
More informationMeeting the Nutritional Requirements of Individuals with Dementia
Unit 15: Understanding and Meeting the Nutritinal Requirements f Individuals with Dementia Unit reference number: D/616/7124 Level: 3 Unit type: Optinal Credit value: 3 Guided learning hurs: 26 Unit summary
More informationContinuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator
Cntinuus Quality Imprvement: Treatment Recrd Reviews Third Thursday Prvider Call (August 20, 2015) Wendy Bwlin, QM Administratr Gals f the Presentatin Review the findings f Treatment Recrd Review results
More informationNutrition Care Process Model Tutorials. Nutrition Monitoring & Evaluation: Overview & Definition. By the end of this module, the participant will:
Nutritin Care Prcess Mdel Tutrials Nutritin Care Prcess and Terminlgy Cmmittee Academy f Nutritin and Dietetics Nutritin Care Prcess Terminlgy 2015 Editin Nutritin Mnitring & Evaluatin: Overview & Definitin
More informationPublic consultation on the NHMRC s draft revised Australian alcohol guidelines for low-risk drinking
Public cnsultatin n the NHMRC s draft revised Australian alchl guidelines fr lw-risk drinking Recmmendatins frm The Cancer Cuncil Australia The Cancer Cuncil Australia is Australia s peak nn-gvernment
More informationAgenda Item 3 CX/FL 17/44/3 Add 1 September 2017
E Agenda Item 3 CX/FL 17/44/3 Add 1 September 2017 1. Intrductin JOINT FAO/WHO FOOD STANDARDS PROGRAMME CODEX COMMITTEE ON FOOD LABELLING 44 th Sessin Asunción, Paraguay, 16 20 Octber 2017 DISCUSSION PAPER
More information2018 CMS Web Interface
CMS Web Interface MH-1 (NQF 0710): Depressin Remissin at Twelve Mnths Measure Steward: MNCM CMS Web Interface V2.0 Page 1 f 27 11/13/2017 Cntents INTRODUCTION... 4 CMS WEB INTERFACE SAMPLING INFORMATION...
More informationP02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017
P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin Revisin 1.9 July 26, 2017 P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin TABLE OF CONTENTS TABLE OF CONTENTS...
More informationState Health Improvement Plan Choosing Priorities, Creating a Plan. DHHS DPH - SHIP Priorities (Sept2016) 1
State Health Imprvement Plan 2017-2021 Chsing Pririties, Creating a Plan DHHS DPH - SHIP Pririties (Sept2016) 1 Creating a Plan: 2017-2021 SHIP Welcme! Wh s here? What is the State Health Imprvement Plan
More informationEXECUTIVE SUMMARY INNOVATION IS THE KEY TO CHANGING THE PARADIGM FOR THE TREATMENT OF PAIN AND ADDICTION TO CREATE AN AMERICA FREE OF OPIOID ADDICTION
EXECUTIVE SUMMARY INNOVATION IS THE KEY TO CHANGING THE PARADIGM FOR THE TREATMENT OF PAIN AND ADDICTION TO CREATE AN AMERICA FREE OF OPIOID ADDICTION The Bitechnlgy Innvatin Organizatin (BIO) and ur member
More informationHerbal Medicines: Traditional Herbal Registration
Herbal Medicines: Traditinal Herbal Registratin In the UK, cmpanies can nly sell herbal medicines with the apprpriate prduct licence, as fllws: A full marketing authrisatin based n the safety, quality
More information1100 Marie Mount Hall College Park, Maryland Tel: (301) Fax: (301)
UNIVERSITY SENATE 1100 Marie Munt Hall Cllege Park, Maryland 20742-7541 Tel: (301) 405-5805 Fax: (301) 405-5749 http://www.senate.umd.edu March 31, 2017 Jrdan Gdman Chair, University Senate 2208G Physical
More informationMGPR Training Courses Guide
MGPR Training Curses Guide fiscal cde 92107050921 1. Descriptin The training prgram supprted by MGPR is prpsed by a grup f excellent mentrs/educatrs, accmplished in Pesticides Management and Analysis,
More informationUNIT 6. DEVELOPING THREAT/HAZARD-SPECIFIC ANNEXES
UNIT 6. DEVELOPING THREAT/HAZARD-SPECIFIC ANNEXES This page intentinally left blank. UNIT INTRODUCTION Visual 6.1 This unit presents infrmatin n annexes that shuld be included in a schl emergency peratins
More informationTrue Patient & Partner Engagement How is it done? How can I do it?
True Patient & Partner Engagement Hw is it dne? Hw can I d it? GROUP TECHNICAL ASSISTANCE JANUARY 18, 2017 COLORADO FOUNDATION FOR PUBLIC HEALTH AND THE ENVIRONMENT Webinar Objectives 1. Describe patient
More informationREGISTERED REPORTS AUTHOR AND REVIEWER GUIDELINES
REGISTERED REPORTS AUTHOR AND REVIEWER GUIDELINES A Registered Reprt is a frm f empirical article ffered at Nature Human Behaviur in which the methds and prpsed analyses are pre-registered and reviewed
More informationSpecifically, on page 12 of the current evicore draft, we find the statement:
Octber 23, 2016 evicre Healthcare Attn: Dr Greg Allen 400 Buckwalter Place Bulevard Blufftn, SC 29910 RE: evicre Draft Onclgy Imaging Guidelines, v 19.0 Gentlepersns: Prstate Cancer Internatinal is a nt-fr-prfit
More informationA pre-conference should include the following: an introduction, a discussion based on the review of lesson materials, and a summary of next steps.
NAU Mdel Observatin Prtcl The mdel prtcl was develped with supprt and expertise frm the Natinal Institute fr Excellence in Teaching (NIET) and is based in great part n NIET s extensive experience cnducting
More informationTERMS OF REFERENCE (ToR) NATIONAL INDIVIDUAL CONSULTANCY
TERMS OF REFERENCE (TR) NATIONAL INDIVIDUAL CONSULTANCY T Develping training materials fr a Human Develpment Mdule Applicatin Type: External vacancy Jb Title: Individual Cnsultancy (IC) Categry: Duty Statin:
More information2017 CMS Web Interface
CMS Web Interface PREV-12 (NQF 0418): Preventive Care and Screening: Screening fr Depressin and Fllw-Up Measure Steward: CMS Web Interface V1.0 Page 1 f 22 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE
More informationDRAFT EMEA PANDEMIC INFLUENZA CRISIS MANAGEMENT PLAN FOR THE EVALUATION AND MAINTENANCE OF PANDEMIC INFLUENZA VACCINES AND ANTIVIRALS
Eurpean Medicines Agency Lndn, 14 Nvember 2005 Dc. Ref. EMEA/397403/2005 DRAFT EMEA PANDEMIC INFLUENZA CRISIS MANAGEMENT PLAN FOR THE EVALUATION AND MAINTENANCE OF PANDEMIC INFLUENZA VACCINES AND ANTIVIRALS
More informationTASKFORCE REPORT AIMS TO BOOST CANCER SURVIVAL AND TRANSFORM PATIENT EXPERIENCE
Sunday 19 July, 2015 TASKFORCE REPORT AIMS TO BOOST CANCER SURVIVAL AND TRANSFORM PATIENT EXPERIENCE SIX STRATEGIC pririties have tday (Sunday) been recmmended by the Independent Cancer Taskfrce t help
More informationPolicy Guidelines: Genetic Testing for Carrier Screening and Reproductive Planning
Plicy Guidelines: Genetic Testing fr Carrier Screening and Reprductive Planning Cntents Overview... 1 Cverage guidelines... 2 General cverage guidelines... 2 Rutine carrier screening... 2 Carrier screening
More informationBreast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)
Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages
More informationAssessment criteria for Primary Health Disciplines Eligibility for Recognition as Credentialled Diabetes Educator. December 2015 ADEA
Assessment criteria fr Primary Health Disciplines Eligibility fr Recgnitin as Credentialled Diabetes Educatr December 2015 ADEA ASSESSMENT CRITERIA FOR PRIMARY HEALTH DICIPLINES ELIGIBILITY FOR RECOGNITION
More informationCardiac Rehabilitation Services
Dcumentatin Guidance N. DG1011 Cardiac Rehabilitatin Services Revisin Letter A 1.0 Purpse The Centers fr Medicare and Medicaid Services (CMS) has detailed specific dcumentatin requirements fr Cardiac Rehabilitatin
More informationImplementation of G6PD testing and radical cure in P. vivax endemic countries: considerations
Implementatin f G6PD testing and radical cure in P. vivax endemic cuntries: cnsideratins Malaria Plicy Advisry Cmmittee Geneva, Switzerland 16-18 September 2015 1 WHO Guidelines n Radical Cure WHO guidelines
More informationHSC 106 Personal Health Plan for Learning Activities & Assessment linked to Michigan Teacher Preparation Standards
HSC 106 Persnal Health Plan fr Learning Activities & Assessment linked t Michigan Teacher Preparatin Standards Standard 1 Cmpetency 1.1 Understand basic health cntent as it relates t schl health educatin.
More informationSwindon Joint Strategic Needs Assessment Bulletin
Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical
More informationDementia Cal MediConnect Project DEMENTIA CARE MANAGER TRAINING FACILITATOR GUIDE
Dementia Cal MediCnnect Prject DEMENTIA CARE MANAGER TRAINING FACILITATOR GUIDE This prject is supprted, in part by grant numbers 90DS2002-01-00 and 90DS2017-01-00, frm the Administratin n Aging, U.S.
More informationPROVIDER ALERT. Comprehensive Diagnostic Evaluation (CDE) Guidelines to Access the Applied Behavior Analysis (ABA) Benefit.
Cmprehensive Diagnstic Evaluatin (CDE) Guidelines t Access the Applied Behavir Analysis (ABA) Benefit May 5, 2017 Clinical infrmatin that utlines medical necessity is required t supprt the need fr initial
More informationA Unified Approach to Conflict Mineral Compliance for the Tungsten Industry. The Westin, Sydney, 23 September 2013
A Unified Apprach t Cnflict Mineral Cmpliance fr the Tungsten Industry The Westin, Sydney, 23 September 2013 Backgrund Cmpliance f public US dwnstream tungsten users with the reprting requirements f the
More informationCriminal Justice Social Work
Criminal Justice Scial Wrk A curriculum fr prbatin wrk frm a Eurpean perspective Frank Philippart Angèle Geerts Centre fr Public Safety & Criminal Justice Avans University f Applied Sciences Den Bsch The
More informationStrategic Plan Publication No: EO-SP
Strategic Plan 2017-2019 Publicatin N: EO-SP-170223 +61 2 9036 5002 www.pcg.rg.au pcg.ffice@sydney.edu.au This dcument was prepared by the PCG Executive Office PCG Publicatin number: EO-SP-170223 Psych-nclgy
More informationA fake medicine that passes itself off as a real, authorised medicine. (1)
Falsified medicines Index 1 Intrductin 2 Types f falsified medicines 3 Eurpean regulatin n falsified medicines 4 Risks f falsified medicines 5 Buying medicine nline safely 6 References 7 Further resurces
More informationLEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST
OPTUM LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY / APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED
More informationPREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland
AWARD NUMBER: W81XWH-14-1-0444 TITLE: Culd HER2 Hetergeneity Open New Therapeutic Optins in Patients with HER2- Primary Breast Cancer? PRINCIPAL INVESTIGATOR: Gary Ulaner, MD, PhD CONTRACTING ORGANIZATION:
More informationSafety of HPV vaccination: A FIGO STATEMENT
FIGO Statement n HPV Vaccinatin Safety, August 2nd, 2013 Safety f HPV vaccinatin: A FIGO STATEMENT July, 2013 Human papillmavirus vaccines are used in many cuntries; glbally, mre than 175 millin dses have
More informationCnsideratin fr Optimizatin: Optimizatin is a prgram transfrmatin technique, which tries t imprve the cde by making it cnsume fewer resurces (i.e. CPU, Memry) and deliver high speed. In ptimizatin, high-level
More informationApproaches to the Care and Support of Individuals with Dementia
Unit 14: Persn-centred Appraches t the Care and Supprt f Individuals with Dementia Unit reference number: H/601/2879 Level: 2 Unit type: Optinal Credit value: 2 Guided learning hurs: 17 Unit summary Understanding
More informationDATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS
DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 216 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS This briefing has been specifically prepared fr the Ministry f Health t prvide infrmatin frm this
More informationHIS Registry of Ministry Resources
HIS Registry f Ministry Resurces Date: 2006-10-11 Status: Abstract: Editr: Changes since previus versin: Adpted Registry This registry is adpted by the HIS Stewards and ready fr use by members f the HIS
More informationSTATISTICAL ANALYSIS PLAN. Addendum 1 (V 1 12SEP2015)
Pelvic Flr Disrder STATISTICAL ANALYSIS PLAN Addendum 1 (V 1 12SEP2015) PFDN Prtcl Number 22P01: Refractry Overactive Bladder: Sacral NEurmdulatin v. BTulinum Txin Assessment (ROSETTA) AUTHOR (S): Tracy
More informationSUMMARY THE EUROPEAN COMMUNITY STRATEGY
SUMMARY THE EUROPEAN COMMUNITY STRATEGY FOR THE PHASEOUT OF CFCS IN MDIS 1. The Eurpean Cmmunity s transitin strategy fr the phaseut f CFCs in metered-dse inhalers (MDIs) was submitted t the Parties t
More informationNovel methods and approaches for sensing, evaluating, modulating and regulating mood and emotional states.
Nvel methds and appraches fr sensing, evaluating, mdulating and regulating md and emtinal states. 2018 Jy Academic Grant Call fr Prpsals Intrductin The Annual Jy grant initiative aims t prmte and cntribute
More informationIndividual Assessments for Couples Treatment with HFCA
Individual Assessments fr Cuples Treatment with HFCA Jennifer S. Ripley, Ph.D. Many appraches t cuples therapy include an individual assessment whenever a cuple cmes fr treatment. Therapists shuld be aware
More informationHow to become an AME Online
Hw t becme an AME Online 1. Check that yu meet the minimum technical requirements in rder t use the AME Online system: Operating System: Windws Vista (Service Pack 2) Windws 7 Windws 8, 8.1 Windws 10 Please
More informationHOSA 105 EMERGENCY PREPAREDNESS
HOSA 105 EMERGENCY PREPAREDNESS MODULE 2: MEDICAL RESERVE CORPS (MRC) PURPOSE The Medical Reserve Crps (MRC) is an imprtant part f the Citizen Crps. The prgram reprts directly t Surgen General f the U.S.
More informationCSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009
CSHCN Services Prgram Benefits t Change fr Outpatient Behaviral Health Services Infrmatin psted Nvember 10, 2009 Effective fr dates f service n r after January 1, 2010, benefit criteria fr utpatient behaviral
More information2018 CMS Web Interface
CMS Web Interface PREV-12 (NQF 0418): Preventive Care and Screening: Screening fr Depressin and Measure Steward: CMS CMS Web Interface V2.1 Page 1 f 23 06/25/ Cntents INTRODUCTION... 3 CMS WEB INTERFACE
More informationAwareness of Autistic Spectrum Conditions
Unit 21: Awareness f Autistic Spectrum Cnditins Unit reference number: H/616/7304 Level: 2 Unit type: Optinal Credit value: 2 Guided learning hurs: 17 Unit summary This unit intrduces yu t autistic spectrum
More informationWHAT IS HEAD AND NECK CANCER FACT SHEET
WHAT IS HEAD AND NECK CANCER FACT SHEET This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice
More information23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)
Intrductin & Aims Drug and Alchl Cnsultatin Liaisn (AOD CL) services aim t imprve identificatin and treatment f patients with AOD mrbidity. The csts and cnsequences f targeting AOD patients presenting
More informationProcedural Advice to CHMP Members
Eurpean Medicines Agency Pst-authrisatin Evaluatin f Medicines fr Human Use Lndn, 6 th August 2008 Dc. Ref.: EMEA/361945/2007 Editin 00 Editin date: July 2008 EDITION 1 DATE PAGE/S REASON FOR CHANGE 00
More informationPromoting Health and Preventing Disease: The EU Health Promotion and Disease Prevention Knowledge Gateway
Prmting Health and Preventing Disease: The EU Health Prmtin and Disease Preventin Knwledge Gateway Stefan Strcksdieck genannt Bnsmann n behalf f Petrs A. Maragkudakis, Ianna Bakgianni, Susanne Safkan,
More informationPain Management Learning Plan
Pain Management Learning Plan Overriding Gal T imprve the quality f patient care available fr patients living with chrnic pain. Learning Outcmes By the end f the implementatin, participants will be able
More informationMedicare Advantage 2019 Advance Notice Part 1 21 st Century Cures Act Methodological Changes
Medicare Advantage 2019 Advance Ntice Part 1 21 st Century Cures Act Methdlgical Changes Review f Relevant Prvisins with Expert Insight January 2018 PULSE8 is privileged t bring yu a summary f key Medicare
More informationFrequently Asked Questions: IS RT-Q-PCR Testing
Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld
More informationREHAB DEFINITIONS INITIATIVE FINAL REPORT MARCH 2010
REHAB DEFINITIONS INITIATIVE FINAL REPORT MARCH 2010 Submitted by: GTA Rehab Netwrk Submitted t: TORONTO CENTRAL LHIN March 31, 2010 TABLE OF CONTENTS Acknwledgements i 1.0 Executive Summary.. 1 2.0 Backgrund.
More informationObesity/Morbid Obesity/BMI
Obesity/mrbid besity/bdy mass index (adult) Obesity/Mrbid Obesity/BMI Definitins and backgrund Diagnsis cde assignment is based n the prvider s clinical judgment and crrespnding medical recrd dcumentatin
More informationPennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain
Pennsylvania Guidelines n the Use f Opiids t Treat Chrnic Nncancer Pain Chrnic pain is a majr health prblem in the United States, ccurring with a pintprevalence f abut ne-third f the US ppulatin.(1) Mre
More informationIntroduction Teaching Interpretation
Intrductin Teaching Interpretatin AUTHOR: Kyle Vanderwall Grandville High Schl, Grandville, MI Intrductin The AP U.S. Histry Curriculum Framewrk defines interpretatin in the fllwing way: Interpretatin
More informationAPESB and Auditor Independence
APESB and Auditr Independence Financial Reprting Cuncil Audit Quality Cmmittee 14 May 2014 Channa Wijesinghe MBA, FCPA, FCA Technical Directr Overview Rle f the Accunting Prfessinal & Ethical Standards
More informationData Fusion for Predicting Breast Cancer Survival
Data Fusin fr Predicting Breast Cancer Linbailu Jiang, Yufei Zhang, Siyi Peng Mentr: Irene Kaplw December 11, 2015 1 Intrductin 1.1 Backgrund Cancer is mre f a severe health issue than ever in ur current
More informationEVALUATION OF POVERTY AND STIGMA SESSIONS
Questin 1 As a result f participating in this sessin, my awareness f pverty has: Numbers lt 43 37 6 Ttal 86 lt Qutes / Cmments Already wrk clsely with emplyability pipeline and welfare rights Very infrmative
More informationEXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS
1 SECTION 1 INTRODUCTION: EXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS The Nature Of Assessment The Definitin Of Assessment The Difference Between Testing, Measurement And Evaluatin Characteristics
More informationGREAT CHART PRIMARY SCHOOL HISTORY POLICY
GREAT CHART PRIMARY SCHOOL HISTORY POLICY July 2018 Our visin is t create a schl cmmunity where children participate, succeed and are prud f their achievements. We strive t actively prmte British values
More informationAncillary Symposia Request for Proposals Partner with the Endocrine Society to Educatte the Endocrine Community.
Ancillary Sympsia Request fr Prpsals Partnerr with the Endcrine Sciety t Educate the Endcrine Cmmunity. Jin the Endcrine Sciety in Bstn fr the 98 th Annual Meeting & Exp frm April 1 4, 2016. ENDO 2016
More informationRecommendations for Risk Management at Swine Exhibitions and for Show Pigs August 2012
Recmmendatins fr Risk Management at Swine Exhibitins and fr Shw Pigs August 2012 Backgrund: The Natinal Prk Bard facilitated in develping this dcument. These recmmendatins were develped by a wrking grup
More informationReliability and Validity Plan 2017
Reliability and Validity Plan 2017 Frm CAEP The principles fr measures used in the CAEP accreditatin prcess include: (a) validity and reliability, (b) relevance, (c) verifiability, (d) representativeness,
More informationPROCEDURAL SAFEGUARDS NOTICE PARENTAL RIGHTS FOR PRIVATE SCHOOL SPECIAL EDUCATION STUDENTS
PROCEDURAL SAFEGUARDS NOTICE PARENTAL RIGHTS FOR PRIVATE SCHOOL SPECIAL EDUCATION STUDENTS INTRODUCTION This ntice prvides an verview f the parental special educatin rights, smetimes called prcedural safeguards
More informationCode of employment practice on infant feeding
Cde f emplyment practice n infant feeding An Emplyer s guide t: Sectin 69Y f the Emplyment Relatins Act 2000 Frewrd As Minister f Labur, I am pleased t publish the Cde f Emplyment Practice n Infant Feeding.
More informationTELCOMMUNICATIONS CONSUMER PROTECTIONS CODE (C628:2012) EXPLANATORY STATEMENT
TELCOMMUNICATIONS CONSUMER PROTECTIONS CODE (C628:2012) EXPLANATORY STATEMENT Intrductin This is the Explanatry Statement fr the revised Cmmunicatins Alliance Telecmmunicatins Cnsumer Prtectins (TCP) Industry
More informationWeight Assessment and Counseling for Children and Adolescents (NQF 0024)
Weight Assessment and Cunseling fr Children and Adlescents (NQF 0024) EMeasure Name Weight Assessment and EMeasure Id Pending Cunseling fr Children and Adlescents Versin Number 1 Set Id Pending Available
More informationFIGHT DEMENTIA ACTION PLAN
FIGHT DEMENTIA ACTION PLAN DEMENTIA IS A HEALTH PRIORITY Dementia will be the majr health prblem f this century. Over ne millin Australians are already affected by the disease themselves r are caring fr
More informationKessler Foundation West Orange, NJ PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland
AWARD NUMBER: W81XWH-16-1-0726 TITLE: A Randmized Cntrlled Trial f the Grup-Based Mdified Stry Memry Technique in TBI PRINCIPAL INVESTIGATOR: Nancy D. Chiaravallti, PhD CONTRACTING ORGANIZATION: Kessler
More informationSUFFOLK COUNTY COUNCIL. Anti- Social Behaviour Act Penalty Notice. Code of conduct
SUFFOLK COUNTY COUNCIL Anti- Scial Behaviur Act 2003 Penalty Ntice Cde f cnduct SCC Penalty Ntice Cde f Cnduct & Administrative Guidance: revised August 2014 1 Cntents 1. Legal Basis 2. Purpse f the Penalty
More informationHuman papillomavirus (HPV) refers to a group of more than 150 related viruses.
HUMAN PAPILLOMAVIRUS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between
More informationFull-time or part-time to a minimum of 0.8FTE (30 hours per week) Job Reference: CLS00161
Jb Title: Medical Statistician Grade: 8 Salary: 42,418 t 47,722 per annum Department: Research Design Service (RDS) and Leicester Clinical Trials Unit (LCTU) Cntract: Open ended cntract subject t fixed
More informationNon-assurance Services
IFAC Bard Rundtable Briefing Nte May 2018 Internatinal Ethics Standards Bard fr Accuntants Nn-assurance Services Explring Issues t Determine a Way Frward This dcument has been prepared by the IESBA Nn-assurance
More informationBedfordshire and Hertfordshire DRAFT Priorities forum statement Number: Subject: Prostatism Date of decision: January 2010 Date of review:
Bedfrdshire and Hertfrdshire DRAFT Pririties frum statement Number: Subject: Prstatism Date f decisin: January 2010 Date f review: Referral criteria Mst men with lwer urinary tract symptms due t benign
More information